Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease
- 28 February 2007
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 203 (2), 512-520
- https://doi.org/10.1016/j.expneurol.2006.09.004
Abstract
No abstract availableKeywords
Funding Information
- Michael J. Fox Foundation for Parkinson's Research
- National Institutes of Health (NS36157)
This publication has 42 references indexed in Scilit:
- Energy Status, Ubiquitin Proteasomal Function, and Oxidative Stress During Chronic and Acute Complex I Inhibition with Rotenone in Mesencephalic CulturesAntioxidants and Redox Signaling, 2005
- Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's diseaseNeuroscience Letters, 2004
- Systemic administration of N‐acetylcysteine protects dopaminergic neurons against 6‐hydroxydopamine‐induced degenerationJournal of Neuroscience Research, 2004
- Superoxide activates mitochondrial uncoupling proteinsNature, 2002
- Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrationsCarcinogenesis: Integrative Cancer Research, 1995
- A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's diseaseAnnals of Neurology, 1992
- Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat.JCI Insight, 1990
- L-Cysteine, a Bicarbonate-Sensitive Endogenous ExcitotoxinScience, 1990
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986
- Cysteine and Cystine Transport at the Blood‐Brain BarrierJournal of Neurochemistry, 1982